Skip to the page

Data / Form D filings / ElectraDx, Inc.

ElectraDx, Inc.: Form D filings

ElectraDx, Inc., a health care company in Boston, MA, filed 2 Form D notices with the SEC in 2024. The latest, on March 20, 2024, reports $14.8 million sold of a $20 million offering to 22 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
C/O RUBERTO, ISRAEL & WEINER, P.C., 255 STATE STREET, 7TH FLOOR, Boston, MA, 02109
Phone
(339) 221-6282
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2015659

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 20, 2024New notice$20,000,000$14,760,000$5,240,00022Feb 21, 2024sec.gov
Mar 19, 2024New notice$6,280$6,28057Dec 22, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ron ZwanzigerExecutive Officer, Director
Jerome McAleerExecutive Officer, Director
David ScottExecutive Officer, Director

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Mar 18, 2024 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what ElectraDx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.